It has been several centuries since the deadly bubonic plague that wreaked havoc in Europe. However, it seems that the highly contagious illness is making a return, with a fourth case recently reported in China.
Express reports that the latest case is coming from Mongolia, where the three previous cases came from. This time, it was a farmer from the Siziwang county, who was diagnosed and immediately treated in the local hospital. He is currently in a stable condition now, however, four people who came into contact with him are now placed under quarantine.
According to the health officials in China, it is indeed a case of the bubonic or “Black Plague” rather than the pneumonic plague. The bubonic plague includes swelling of the lymph nodes in the body. The pneumonic plague is the illness that affects the lungs and thus is airborne and transmitting the disease is easier. While this latest case is a confirmed bubonic plague case, two out of the three previous cases were that of the pneumonic plague.
Fortunately, no fatalities have been reported from any of the three cases.
University of East Anglia Professor Paul Hunter said that the two pneumonic plague cases are the bigger concern. Hunter explains that this is because, in the bubonic plague which was usually transmitted by rats and the fleas in the rats, the lymph nodes swell and then there is a discharge. Another reason why the pneumonic plague is the bigger concern is that if left untreated, it can be fatal.
“You can spread it from person to person as you’re coughing, the bacteria then drifts into the air and you inhale it,” Says Hunter.
The three previous cases in Inner Mongolia reportedly contracted the disease by consuming wild animals. Plague cases in China are generally not uncommon, and disease outbreaks are very rare as well. There were only 26 cases and 11 casualties in China due to diseases from 2009 to 2018.
The bubonic plague was also known as the “Black Plague” or the “Black Death” during the 14th century. The illness that swept through three continents at the time killed 50 million people and 25 percent of the European population.


Bayer’s Stroke Drug Achieves Breakthrough Trial Results, Boosting Market Confidence
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
U.S. Reveals 2026 Medicare Star Ratings: Aetna, UnitedHealth Lead in Quality Scores
Trump Signs Executive Order to Boost AI Research in Childhood Cancer
Merck Nears Acquisition of Cidara Therapeutics at Significant Premium
Novartis to Acquire Avidity Biosciences for $12 Billion to Strengthen Rare Muscle Disorder Portfolio
Major Drugmakers Slash U.S. Prices and Sell Directly to Patients Amid Trump’s Push for Affordable Medicines
Trump Backs Review of U.S. Childhood Vaccine Schedule After Hepatitis B Policy Change
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
Trump Hints at Major Autism Announcement, Raises Questions on Tylenol Link
Eli Lilly Becomes First Pharma Giant to Hit $1 Trillion Amid Soaring Weight-Loss Drug Demand
Obamacare Premiums Set to Double in 2026 as Subsidy Expiration Looms Amid U.S. Shutdown
Pfizer Sues Novo Nordisk Over Alleged Tactics to Block Obesity Drug Competition
Novo Nordisk Appoints Greg Miley as Global Head of Corporate Affairs Amid U.S. Pricing Pressure
Canada Loses Measles-Free Status After Nearly 30 Years Amid Declining Vaccination Rates
FDA Memo Raises Questions About Possible COVID-19 Vaccine Links to Rare Child Deaths 



